Clinical Trial Update: Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 Boehringer Ingelheim trial evaluating withdrawal of inhaled corticosteroids in chronic obstructive pulmonary disease; results posted on 2015-02-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2015-02-10